BlackRock Health Sciences Term Trust (NYSE:BMEZ) Short Interest Update

BlackRock Health Sciences Term Trust (NYSE:BMEZ) saw a significant drop in short interest in the month of January. As of January 30th, there was short interest totaling 8,067 shares, a drop of 93.6% from the January 15th total of 126,819 shares. Based on an average daily trading volume, of 392,314 shares, the days-to-cover ratio is presently 0.0 days. Based on an average daily trading volume, of 392,314 shares, the days-to-cover ratio is presently 0.0 days.

Insider Transactions at BlackRock Health Sciences Term Trust

In related news, Director Robert W. Fairbairn sold 10,294 shares of the business’s stock in a transaction that occurred on Thursday, December 18th. The shares were sold at an average price of $14.98, for a total value of $154,204.12. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Institutional Trading of BlackRock Health Sciences Term Trust

A number of institutional investors have recently modified their holdings of BMEZ. Invesco Ltd. grew its holdings in shares of BlackRock Health Sciences Term Trust by 42.7% during the third quarter. Invesco Ltd. now owns 929,121 shares of the company’s stock valued at $13,398,000 after buying an additional 278,024 shares during the last quarter. Wolverine Asset Management LLC lifted its position in BlackRock Health Sciences Term Trust by 5,782.1% during the 3rd quarter. Wolverine Asset Management LLC now owns 224,518 shares of the company’s stock worth $3,238,000 after acquiring an additional 220,701 shares during the period. Readystate Asset Management LP grew its stake in BlackRock Health Sciences Term Trust by 664.6% during the 3rd quarter. Readystate Asset Management LP now owns 247,074 shares of the company’s stock valued at $3,563,000 after purchasing an additional 214,761 shares during the last quarter. Shaker Financial Services LLC acquired a new position in shares of BlackRock Health Sciences Term Trust in the third quarter valued at about $2,654,000. Finally, Penserra Capital Management LLC increased its holdings in shares of BlackRock Health Sciences Term Trust by 15.2% in the third quarter. Penserra Capital Management LLC now owns 1,332,633 shares of the company’s stock valued at $19,216,000 after purchasing an additional 175,629 shares during the period.

BlackRock Health Sciences Term Trust Trading Down 0.1%

Shares of NYSE:BMEZ traded down $0.02 on Tuesday, reaching $15.05. The company had a trading volume of 191,551 shares, compared to its average volume of 343,665. BlackRock Health Sciences Term Trust has a 52-week low of $12.58 and a 52-week high of $16.20. The firm’s 50 day simple moving average is $15.26 and its 200-day simple moving average is $14.81.

BlackRock Health Sciences Term Trust Dividend Announcement

The business also recently announced a monthly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Friday, March 13th will be paid a $0.11 dividend. This represents a c) annualized dividend and a yield of 8.8%. The ex-dividend date is Friday, March 13th.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.